US FDA•United StatesCRL•Complete Response Letter
Complete Response Letter NDA 505b1 212271 (Dec 11, 2024)
Issued December 11, 2024
Issued
December 11, 2024
Application
NDA 505b1 • 212271
Review center
CDER
Stage
Final Decision
Letter type
Complete Response Letter
Response due December 11, 2025Requires resubmission addressing deficiencies.
Document viewer
Read the FDA letter and send context to the co-pilot at any time.